Solutions Through Advanced Research Inc.

Jacksonville, Florida

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Scabies Clinical Trial
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to ElimiteĀ® in the Treatment of Scabies
Status: Enrolling, Phase III
Updated: 10/30/2015
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Psoriasis Clinical Trial
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials